MedPath

Influence of intraoperative use of remifentanil to postpoerative nausea and vomiting(PONV)

Not Applicable
Conditions
upper extremity surgery
Registration Number
JPRN-UMIN000016110
Lead Sponsor
iigata University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who did not consent Patients with allergy of local anesthetics Pregnant or lactating women Patients with liver failure or renal failure Patients with bradycardia(HR<40bpm)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The incidence of postoperative nausea
Secondary Outcome Measures
NameTimeMethod
Respiratory rate at the time of leaving Time until spontaneous breathing appear Total dose of remifentanil End-tidal sevoflurane concentration at the time of awakening NRS at rest
© Copyright 2025. All Rights Reserved by MedPath